SCHEMBL7009643

SCHEMBL7009643

CCOC(=O)c1ccc(/C=C/C(=O)C(N)c2cccn2-c2ccc(Cl)c(CO[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)c2Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 17/20 0.38
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
PLA2G1B P04054 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
ATG4B Q9Y4P1 1/20 0.32
PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7009603 0.91 BDKRB2 (0.34) BDKRB2
SCHEMBL7010294 0.89 BDKRB2 (0.47) BDKRB2
SCHEMBL7015355 0.85 BDKRB2 (0.37) BDKRB2MEN1ALDH1A1LMNAPLA2G1B
SCHEMBL7654571 0.84 BDKRB2 (0.37) BDKRB2
SCHEMBL7009647 0.84 BDKRB2 (0.55) BDKRB2
SCHEMBL7009650 0.84 BDKRB2 (0.55) BDKRB2
SCHEMBL7013353 0.79 GABRB2 (0.38) BDKRB2ALDH1A1LMNAPOLBMAPT
SCHEMBL8719698 0.78 BDKRB2 (0.51) BDKRB2
SCHEMBL7012997 0.76 BDKRB2 (0.35) BDKRB2
SCHEMBL7009610 0.75 BDKRB2 (0.50) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861243-B1 HETEROCYCLIC COMPOUNDS AS BRADYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-11-12 EP disclosed
US-6344462-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-05 US disclosed
US-6100284-A ANTIALLERGENS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-08 US disclosed
US-6008229-A TREATING ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed